Maryanne, I did buy the book. I haven’t finished it because sometimes I need to get away from it all and read a novel or some other such distraction. From the substack midwestern doctor, I watched a clip from 60 minutes on the swine flu in 1976, it’s was all the same obfuscation as now. It angers me that no diagnostic tests exist nor medical codes. Cancer rates are up worldwide but governments are side stepping that one too, they’re blaming it on everything else but the real cause. In their mind it can’t be due to the shots because of the amount of time gone by past the shot. I don’t know what the upshot of all of their denials is going to be, but in my mind it’s imperative we have diagnostics.
Pity they remained BLIND to the Australian antiviral nasal spray VIRALEZE™ using Astodrimer sodium dendrimer by CSIRO which Morrison is probably implicated in killing even though it was MRFF BTB award winner. How can any authors on this topic miss this out. Europe re-approved it under new 2025 MDR Class2a but Australian 4 years after are delivered of prophylactic and TREATMENT with better efficacy in standard risk than Paxlovid. Surely it warranted a mention in this book although maybe all those health professional authors are scared of being fined themselves for infringing / RESTRICTED REPRESENTATIONS
MaryAnne this is such an opportunity missed - with authors missing one of the worst Australians killings of its own inventions in the pandemic
So - Let down again - even the critics of the Australian responses seem muzzled or maybe the censorship has been so strong that no-one will step out with truth
I bought this book Maryanne faintly expecting (hoping❓) there would be mention of a victim of TGA INFRINGEMENT NOTICES - the Astodrimer sodium antiviral nasal spray VIRALEZE with proven RPC efficacy as early COVID treatment - developed from CSIRO DENDRIMERS
1️⃣ Viraleze antiviral nasal sprays by Starpharma 2022 Award by Australian Government dept of health and dept of industry
Starpharma awarded $1 million in matched funding by the Australian Government’s Medical Research Future Fund (MRFF) Biomedical Translation Bridge (BTB) Program to expedite development and commercialisation of VIRALEZE
Winner “Most significant commercial outcome”. DOHAC winner 13 months after TGA (also in DOHAC) irrationally banned & fined product info in Australia despite 35 regulators internationally including European EMA in 2020 approving as Medical Device
2️⃣ Sept 2024 - Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial
7️⃣ Dec 2022 DART conference Astodrimer sodium v other nasal sprays Scripp presentation. In-viva (mouse model) euthanised to study viral load nasal cavity trachea and lung at 4 and 7 days. Comparators nitric oxide, HPMC, heparin, iota-carrageenan, Astodrimer sodium (Viraleze) v saline (PBS)
Victorian State Government report by KPMG January 2021
The research presented in this paper was commissioned by Victoria’s Lead Scientist, Dr Amanda Caples, and the Victorian Department of Jobs, Precincts and Regions (DJPR
Starpharma, an ASX300 company located in Melbourne, has developed a novel antiviral nasal spray, VIRALEZE™, which inactivates more than 99.99 percent of SARS-CoV-2, the virus that causes COVID-19. VIRALEZE™ is a broad spectrum antiviral nasal spray and is virucidal against SARS-CoV-2 and works by blocking the spike proteins on the SARS-CoV-2 and preventing them from binding to host cells thus preventing infection. Starpharma is finalising regulatory documents and manufacturing product in preparation for launch which is planned for the first quarter of 2021. Apart from VIRALEZE™ being a Victorian discovery, critical antiviral testing of the spray was conducted at 360Biolabs at the height of the pandemic in March 2020. Had this testing not been available locally the rapid development of the product would have been significantly compromised. Starpharma was awarded
$1 million in MRFF funding to expedite development and commercialisation of VIRALEZE™
VIRALEZE™
European medical device regulations February 2025:
Earlier this month, Starpharma received certification for ViralezeTM under the new European Union (EU) Medical Device Regulations (MDR). Under the new EU MDR classifications, medical device manufacturers must demonstrate compliance with certain essential requirements and undergo a new conformity assessment process with a Europea pd Notified Body. Achieving EU MDR certification demonstrates that ViralezeTM and the research supporting the product meet the necessary safety and performance
❌❌❌
BUT SEEMS EVEN THOSE CRITICAL OF WHAT HAPPENED IN AUSTRALIA IN THE PANDEMIC, LET MILLIONS OF OVER 12YR OLD AUSTRALIANS DOWN BY NOT EXPOSING THE DEAL MORRISON DID TO GET PFIZER MRNA VAX AND PAXLOVID ON 9 APRIL 2021 as long as the completion from VIRALEZE™ was killed
Povidone-iodine is all the book says any nasal spray - nothing VIRALEZE™, iota-carrageenan, nitric oxide
Plenty of mention of ivermectin and hydroxychloroquine
“….Povidone-iodine (real-time meta-analysis 21 studies) is another simple safe addition to covid therapy regimens: in vitro it kills 99.99% of Covid-19 virus within 30 seconds, and can reduce transmission of infection within an outbreak, with more rapid viral clearance, though clinical benefit is less clear. Covid-19 infection typically starts in the upper respiratory tract and specifically the nasal respiratory epithelium. The primary initial route for entry into the central nervous system is thought to be the olfactory nerve in the nasal cavity. Minimising early replication in the upper respiratory tract may reduce spread within neural tissues. Early or prophylactic nasopharyngeal and oropharyngeal treatment can avoid the consequences of viral replication, though the extent of clinical benefits for the individual requires further study.
In conclusion, it appears that for treatment of Covid-19, clinicalobservational studies published by clinicians often include many drugs claiming impressive results such as 90% reduction of serious outcomes, particularly when subjects with risk factors are selected and treatment begins early. It is less clear which combination is optimal. Hydroxychloroquine and/or ivermectin are generally the base therapy, with the useful addition of easily obtained drugs s as
vitamin D and zinc. Povidine-iodine used as a throat gargle and for hasall irrigation reduces viral transmission by reducing viral load and persistence infected individuals….”
Astodrimer sodium as nasal spray is patented until mid 2030
Approved as medical device class 1 from 2020 by 35 regulators including EU the expert in nano particles
Approval in Australia should be on paper for safety non absorbed MD Class1 but TGA labelled it as not “well established technology” because no other nasal spray uses Astodrimer sodium so it can’t be compared with anything like carrageenan / Vicks first defence both pre pandemic… so having the patent labels it novel and thus can’t qualify in the class 1 that 35 other regulators have no problem with
What happens now is interesting as Europe has new rules and Europea pd Notified Bodies have approved VIRALEZE™ re safety and performance and that it is non pharmacological under mandatory rules May 2025 making VIRALEZE™ only antiviral nasal spray that can make SARS-CoV-2 claim on package MDR CL2a. In November 2024 class2a became the appropriate category for VIRALEZE™ in Australia so they had to withdraw their prev class1 application and under new rules apply for class2a here too and to speed TGA processing “well established technology” is no longer required as proof as it is legislated that the EU certification of MDR class 2a is transferable as only proof needed for Australia for that class
Talk about using red tape delays to help Pfizer who just so happen to have fast track FDA listing for a replacement of Paxlovid PF-07817883 Ibuzatrelvir
Strange that Pfizer won the vax league table and the treatment league table.
Would like to talk to Dr Clancy - even the ALP Victoria state conference motion which was the result of 2 years hard work with many health professionals and seeks VIC Govt advocacy for antiviral nasal sprays VIRALEZE™ (Astodrimer sodium) Nasodine (povidone iodine - in the book) and Heparin under TPC trial 2025 couldn’t excite the interest of ABC, Channel 9, Age/SMH etc as Mark Butler seems to be continue a love in with TGA. TGA continues its order that Australian IP addresses are blocked from accessing viraleze.co preventing legal personal importation scheme purchases.
The efforts to block VIRALEZE™ are beyond normal and for all the healthy under 70 yr olds with zero treatment options frankly criminal..
Meanwhile federal govt spent more than AUKUS on Trumps American big pharma PBS antiviral pills $2.7billion to April this year whilst preventing Australians from buying their own protection
Will any of us ever get back to normal after the devastation of Covid and government coercion and mandates? The US is still grappling with it, and no one has been held accountable yet. The stories in Australia appear to be just as bad. RFKJr and President Trump are doing what they can to change what was done to Americans, but, except for a few losing their jobs, no one has paid the price for their actions.
The National Citizens Inquiry testimonies also continue in Canada this month. Evidence from hundreds of people, all available for viewing on Rumble. Dr David Martin has the exposed the intellectual property pathways and just needs to find a justice system interested in trying the case. Only 1 provincial politician has showed up to testify. One.
That's why Albertans will be voting YES to separation from confederation. We don't need to be governed by corrupt idiots. Alberta Prosperity Project. A costed plan to become a new nation. The banana Republic of Canaduh is no longer required.
Maryanne, I did buy the book. I haven’t finished it because sometimes I need to get away from it all and read a novel or some other such distraction. From the substack midwestern doctor, I watched a clip from 60 minutes on the swine flu in 1976, it’s was all the same obfuscation as now. It angers me that no diagnostic tests exist nor medical codes. Cancer rates are up worldwide but governments are side stepping that one too, they’re blaming it on everything else but the real cause. In their mind it can’t be due to the shots because of the amount of time gone by past the shot. I don’t know what the upshot of all of their denials is going to be, but in my mind it’s imperative we have diagnostics.
I get it—it can be exhausting, especially for those who have to relive the nightmare. Sometimes it’s healthy to step back.
And, with so many credentialed doctors, scientists and such how can they still be recommending these shots? Why aren’t they looking into it?
Bravo to all involved in the production of this book. A very noble and humane motive. Applause for your efforts 👏
(Can I get my copy "autographed" ? 😊)
That's a lot of autographs for one book....! ;-)
Pity they remained BLIND to the Australian antiviral nasal spray VIRALEZE™ using Astodrimer sodium dendrimer by CSIRO which Morrison is probably implicated in killing even though it was MRFF BTB award winner. How can any authors on this topic miss this out. Europe re-approved it under new 2025 MDR Class2a but Australian 4 years after are delivered of prophylactic and TREATMENT with better efficacy in standard risk than Paxlovid. Surely it warranted a mention in this book although maybe all those health professional authors are scared of being fined themselves for infringing / RESTRICTED REPRESENTATIONS
MaryAnne this is such an opportunity missed - with authors missing one of the worst Australians killings of its own inventions in the pandemic
So - Let down again - even the critics of the Australian responses seem muzzled or maybe the censorship has been so strong that no-one will step out with truth
I bought this book Maryanne faintly expecting (hoping❓) there would be mention of a victim of TGA INFRINGEMENT NOTICES - the Astodrimer sodium antiviral nasal spray VIRALEZE with proven RPC efficacy as early COVID treatment - developed from CSIRO DENDRIMERS
see VIRALEZE™ credentials below.
No mention in this book at all when TGA on 2 July 2021 STRANGLED AN MRFF BTB GOVT AWARD WINNING AUSTRALIAN NASAL SPRAY SAFE WITH COVID STATISTICAL EFFICACY https://www.tga.gov.au/news/media-releases/starpharma-holdings-limited-fined-93240-alleged-unlawful-advertising-viraleze-relation-covid-19
📌📌📌
Viraleze credentials
1️⃣ Viraleze antiviral nasal sprays by Starpharma 2022 Award by Australian Government dept of health and dept of industry
Starpharma awarded $1 million in matched funding by the Australian Government’s Medical Research Future Fund (MRFF) Biomedical Translation Bridge (BTB) Program to expedite development and commercialisation of VIRALEZE
Winner “Most significant commercial outcome”. DOHAC winner 13 months after TGA (also in DOHAC) irrationally banned & fined product info in Australia despite 35 regulators internationally including European EMA in 2020 approving as Medical Device
https://biotechdispatch.com.au/news/starpharma-wins-recognition-for-development-of-covid-19-antivira#:~:text=Starpharma%20was%20selected%20by%20an,development%20and%20commercialisation%20of%20VIRALEZE.
2️⃣ Sept 2024 - Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial
https://www.mdpi.com/1999-4923/16/9/1173
PEER REVIEWED PUBLICATION
3️⃣ January 2024 Covid19 viral load post market study placebo based ASX announcement Jan 2024
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02766071-3A635280&v=fc9bdb61fe50ea61f8225e24ce041a0e155a9400
4️⃣ June 2022 Astodrimer sodium human v placebo safety trials reported https://www.researchgate.net/publication/361382162_Astodrimer_sodium_antiviral_nasal_spray_for_reducing_respiratory_infections_is_safe_and_well_tolerated_in_a_randomized_controlled_trial
5️⃣ 2021 Scripp Research Institute in-vito and in-vivo humanised mouse genome Astodrimer sodium studies
https://www.scripps.edu/gallay/sars-cov-2.html
6️⃣ Sept 2024 Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium
https://www.nature.com/articles/s41598-024-72262-w
7️⃣ Dec 2022 DART conference Astodrimer sodium v other nasal sprays Scripp presentation. In-viva (mouse model) euthanised to study viral load nasal cavity trachea and lung at 4 and 7 days. Comparators nitric oxide, HPMC, heparin, iota-carrageenan, Astodrimer sodium (Viraleze) v saline (PBS)
https://starpharma.com/assets/221201-respidart-poster.pdf
Other publications
Nasal delivery as a strategy for the prevention and treatment of COVID-19
See 3.2. Astodrimer sodium
https://www.tandfonline.com/doi/full/10.1080/17425247.2023.2263363#d1e823
Victorian State Government report by KPMG January 2021
The research presented in this paper was commissioned by Victoria’s Lead Scientist, Dr Amanda Caples, and the Victorian Department of Jobs, Precincts and Regions (DJPR
https://djsir.vic.gov.au/__data/assets/pdf_file/0009/1988532/Creating-a-Healthy-Future-Report.pdf
P5; 33
Starpharma, an ASX300 company located in Melbourne, has developed a novel antiviral nasal spray, VIRALEZE™, which inactivates more than 99.99 percent of SARS-CoV-2, the virus that causes COVID-19. VIRALEZE™ is a broad spectrum antiviral nasal spray and is virucidal against SARS-CoV-2 and works by blocking the spike proteins on the SARS-CoV-2 and preventing them from binding to host cells thus preventing infection. Starpharma is finalising regulatory documents and manufacturing product in preparation for launch which is planned for the first quarter of 2021. Apart from VIRALEZE™ being a Victorian discovery, critical antiviral testing of the spray was conducted at 360Biolabs at the height of the pandemic in March 2020. Had this testing not been available locally the rapid development of the product would have been significantly compromised. Starpharma was awarded
$1 million in MRFF funding to expedite development and commercialisation of VIRALEZE™
VIRALEZE™
European medical device regulations February 2025:
Earlier this month, Starpharma received certification for ViralezeTM under the new European Union (EU) Medical Device Regulations (MDR). Under the new EU MDR classifications, medical device manufacturers must demonstrate compliance with certain essential requirements and undergo a new conformity assessment process with a Europea pd Notified Body. Achieving EU MDR certification demonstrates that ViralezeTM and the research supporting the product meet the necessary safety and performance
❌❌❌
BUT SEEMS EVEN THOSE CRITICAL OF WHAT HAPPENED IN AUSTRALIA IN THE PANDEMIC, LET MILLIONS OF OVER 12YR OLD AUSTRALIANS DOWN BY NOT EXPOSING THE DEAL MORRISON DID TO GET PFIZER MRNA VAX AND PAXLOVID ON 9 APRIL 2021 as long as the completion from VIRALEZE™ was killed
Povidone-iodine is all the book says any nasal spray - nothing VIRALEZE™, iota-carrageenan, nitric oxide
Plenty of mention of ivermectin and hydroxychloroquine
“….Povidone-iodine (real-time meta-analysis 21 studies) is another simple safe addition to covid therapy regimens: in vitro it kills 99.99% of Covid-19 virus within 30 seconds, and can reduce transmission of infection within an outbreak, with more rapid viral clearance, though clinical benefit is less clear. Covid-19 infection typically starts in the upper respiratory tract and specifically the nasal respiratory epithelium. The primary initial route for entry into the central nervous system is thought to be the olfactory nerve in the nasal cavity. Minimising early replication in the upper respiratory tract may reduce spread within neural tissues. Early or prophylactic nasopharyngeal and oropharyngeal treatment can avoid the consequences of viral replication, though the extent of clinical benefits for the individual requires further study.
In conclusion, it appears that for treatment of Covid-19, clinicalobservational studies published by clinicians often include many drugs claiming impressive results such as 90% reduction of serious outcomes, particularly when subjects with risk factors are selected and treatment begins early. It is less clear which combination is optimal. Hydroxychloroquine and/or ivermectin are generally the base therapy, with the useful addition of easily obtained drugs s as
vitamin D and zinc. Povidine-iodine used as a throat gargle and for hasall irrigation reduces viral transmission by reducing viral load and persistence infected individuals….”
Would have been great if Prof Clancy had included this from someone who had studied it… like you!!
Btw my research unveiled an interesting Catch 22
Astodrimer sodium as nasal spray is patented until mid 2030
Approved as medical device class 1 from 2020 by 35 regulators including EU the expert in nano particles
Approval in Australia should be on paper for safety non absorbed MD Class1 but TGA labelled it as not “well established technology” because no other nasal spray uses Astodrimer sodium so it can’t be compared with anything like carrageenan / Vicks first defence both pre pandemic… so having the patent labels it novel and thus can’t qualify in the class 1 that 35 other regulators have no problem with
What happens now is interesting as Europe has new rules and Europea pd Notified Bodies have approved VIRALEZE™ re safety and performance and that it is non pharmacological under mandatory rules May 2025 making VIRALEZE™ only antiviral nasal spray that can make SARS-CoV-2 claim on package MDR CL2a. In November 2024 class2a became the appropriate category for VIRALEZE™ in Australia so they had to withdraw their prev class1 application and under new rules apply for class2a here too and to speed TGA processing “well established technology” is no longer required as proof as it is legislated that the EU certification of MDR class 2a is transferable as only proof needed for Australia for that class
Talk about using red tape delays to help Pfizer who just so happen to have fast track FDA listing for a replacement of Paxlovid PF-07817883 Ibuzatrelvir
Strange that Pfizer won the vax league table and the treatment league table.
Would like to talk to Dr Clancy - even the ALP Victoria state conference motion which was the result of 2 years hard work with many health professionals and seeks VIC Govt advocacy for antiviral nasal sprays VIRALEZE™ (Astodrimer sodium) Nasodine (povidone iodine - in the book) and Heparin under TPC trial 2025 couldn’t excite the interest of ABC, Channel 9, Age/SMH etc as Mark Butler seems to be continue a love in with TGA. TGA continues its order that Australian IP addresses are blocked from accessing viraleze.co preventing legal personal importation scheme purchases.
The efforts to block VIRALEZE™ are beyond normal and for all the healthy under 70 yr olds with zero treatment options frankly criminal..
Meanwhile federal govt spent more than AUKUS on Trumps American big pharma PBS antiviral pills $2.7billion to April this year whilst preventing Australians from buying their own protection
Will any of us ever get back to normal after the devastation of Covid and government coercion and mandates? The US is still grappling with it, and no one has been held accountable yet. The stories in Australia appear to be just as bad. RFKJr and President Trump are doing what they can to change what was done to Americans, but, except for a few losing their jobs, no one has paid the price for their actions.
The National Citizens Inquiry testimonies also continue in Canada this month. Evidence from hundreds of people, all available for viewing on Rumble. Dr David Martin has the exposed the intellectual property pathways and just needs to find a justice system interested in trying the case. Only 1 provincial politician has showed up to testify. One.
That's why Albertans will be voting YES to separation from confederation. We don't need to be governed by corrupt idiots. Alberta Prosperity Project. A costed plan to become a new nation. The banana Republic of Canaduh is no longer required.